Skip to main content
Clinical Trials/NCT03155789
NCT03155789
Completed
Not Applicable

Clinical Outcome After Lumbar Fusion for the Treatment of Chronic Low Back Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Low Back Pain
Sponsor
Louisiana State University Health Sciences Center in New Orleans
Enrollment
90
Primary Endpoint
Change from Baseline Visual Analog Scale (VAS)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The main objective of this prospective study is to compare the clinical outcomes after lumbar fusion for chronic low back pain using the four techniques commonly employed in our surgical practice. Lumbar fusion stops motion at a painful vertebral segment, which can decrease back pain. The four techniques are standard transforaminal lumbar interbody fusion (S TLIF), minimally invasive transforaminal lumbar interbody fusion (MI TLIF), extreme lateral interbody fusion (XLIF), and axial lumbar interbody fusion (AxiaLIF). Each differ in where incisions are made and level of invasiveness; not all may be implemented in each surgical case. The four different techniques are all standard approaches with different advantages and have yet to be compared in efficacy for relieving chronic low back pain.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
July 2016
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gabriel C. Tender, MD

Clinical Professor

Louisiana State University Health Sciences Center in New Orleans

Eligibility Criteria

Inclusion Criteria

  • Severe chronic low back pain (at least 7 out of 10 on the VAS scale).
  • Age: 25-65 years.
  • Pain duration at least 2 years.
  • The treating surgeon should interpret the pain as emanating from L4-S
  • The patient must have had unsuccessful maximal possible conservative (non surgical) treatment for at least one year.
  • Radiographic evidence (MRI, CT, CT-SPECT, and/or plain films) of degenerative changes ("spondylosis")

Exclusion Criteria

  • Psychiatric illness or evidence of emotional instability.
  • Previous spine surgery except for successful removal of a herniated disc more than 2 years before entering the study and with no persistent nerve root symptoms.
  • Specific radiologic findings, such as fractures, infection, inflammatory process, or neoplasm.
  • Obvious painful and disabling arthritic hip joints and anamnestic and radiologic signs of spinal stenosis.
  • Involvement in Workman's Comp or litigation.

Outcomes

Primary Outcomes

Change from Baseline Visual Analog Scale (VAS)

Time Frame: 2 weeks, 6 months, 1 year

This is part of the Patient Questionnaire primary outcome measure. A Visual Analogue Scale (VAS) is a measurement instrument that measures the intensity or frequency of pain across a continuum of values.

Change from Baseline Prolo Functional and Economic Score

Time Frame: 2 weeks, 6 months, 1 year

This is part of the Patient Questionnaire primary outcome measure. The Prolo Score is a 10-point scale consisting of only two questions evaluating the functional and economic status of the patient.

Change from Baseline Dallas Pain Questionnaire (DPQ)

Time Frame: 2 weeks, 6 months, 1 year

This is part of the Patient Questionnaire primary outcome measure. The Dallas Pain Questionnaire (DPQ) assess the amount of chronic spine pain that affects the patient's daily and work-leisure activities, anxiety-depression, and social interest.

Change from Baseline Short Form 12 (SF-12)

Time Frame: 2 weeks, 6 months, 1 year

This is part of the Patient Questionnaire primary outcome measure. The Short Form 12 (SF-12) was designed to measure the patient's functional health and well-being.

Change from Baseline Oswestry Disability Index (ODI)

Time Frame: 2 weeks, 6 months, 1 year

This is part of the Patient Questionnaire primary outcome measure. The Oswestry Disability Index measures a patient's impairment and quality of life due to pain.

Secondary Outcomes

  • Radiologic Fusion Rates(6 months and 1 year)

Similar Trials